These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27048878)

  • 1. Nuclear receptor TLX inhibits TGF-β signaling in glioblastoma.
    Johansson E; Zhai Q; Zeng ZJ; Yoshida T; Funa K
    Exp Cell Res; 2016 May; 343(2):118-125. PubMed ID: 27048878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
    Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
    Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
    Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
    Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
    Seystahl K; Tritschler I; Szabo E; Tabatabai G; Weller M
    Neuro Oncol; 2015 Feb; 17(2):254-65. PubMed ID: 25165192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
    Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
    Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
    Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
    Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
    Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P
    Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
    Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
    Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tumor-promoting role for soluble TβRIII in glioblastoma.
    Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
    Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation.
    Li Y; Cui C; Xie F; Kiełbasa S; Mei H; van Dinther M; van Dam H; Bauer A; Zhang L; Ten Dijke P
    J Mol Cell Biol; 2020 Feb; 12(2):138-151. PubMed ID: 31291647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HILI inhibits TGF-β signaling by interacting with Hsp90 and promoting TβR degradation.
    Zhang K; Lu Y; Yang P; Li C; Sun H; Tao D; Liu Y; Zhang S; Ma Y
    PLoS One; 2012; 7(7):e41973. PubMed ID: 22848678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells.
    Fukunaga E; Inoue Y; Komiya S; Horiguchi K; Goto K; Saitoh M; Miyazawa K; Koinuma D; Hanyu A; Imamura T
    J Biol Chem; 2008 Dec; 283(51):35660-7. PubMed ID: 18927080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
    Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
    J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
    Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I
    Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β mimics the key proteome properties of CD133
    Bryukhovetskiy I; Shevchenko V; Arnotskaya N; Kushnir T; Pak O; Victor Z; Zaitsev S; Khotimchenko Y; Bryukhovetskiy A; Sharma A; Sharma HS
    Int Rev Neurobiol; 2020; 151():219-242. PubMed ID: 32448609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
    Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y
    Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
    Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
    Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.